结直肠癌中的TIMP1表达:预后,瘤免疫力和分子通路的联系
Jiming Gu1, Dongming Zhu1, Fan Chen2
1Department of General Surgery, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu 215000, P.R. China.
Oncology letters
|December 1, 2025
概括
矩阵金属蛋白酶1 (TIMP1) 的组织抑制剂在结直肠癌 (CRC) 中表达高,并与预后不佳有关. 高TIMP1与增加的T细胞相关,并影响瘤免疫力和进展途径.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 分子生物学分子生物学
背景情况:
- 矩阵金属蛋白酶1 (TIMP1) 的组织抑制剂在各种癌症中经常过度表达,包括结直肠癌 (CRC).
- 高TIMP1表达通常与几种恶性瘤的不良患者预后有关.
- 需要进行全面的研究才能充分理解TIMP1在CRC中的作用,特别是其预后意义和与瘤免疫的关系.
研究的目的:
- 为了研究结直肠癌 (CRC) 组织中的TIMP1表达水平.
- 为了确定TIMP1在CRC患者的预后值.
- 探索TIMP1表达与瘤免疫透以及CRC中相关分子通路之间的关联.
主要方法:
- 来自癌症基因组图谱 (TCGA),UALCAN和GEPIA2数据库的RNA测序数据和临床信息的综合分析.
- 使用临床CRC样本进行验证.
- 对TIMP1表达与免疫细胞透 (CD4+,CD8+T细胞),瘤突变负担 (TMB),微卫星不稳定性 (MSI) 和关键信号通路的相关性分析.
主要成果:
- 与正常组织相比,TIMP1在CRC组织中显著上调.
- 在CRC中提升的TIMP1表达与患者预后较差相关.
- 高TIMP1水平与CD4+和CD8+T细胞透,TMB和MSI积极相关.
- TIMP1的表达与包括表皮细胞-介质细胞过渡 (EMT),细胞外基质 (ECM) 改造,血管生成,细胞亡,铁亡和TGF-β信号传递在内的途径有关.
结论:
- 在结直肠癌中,TIMP1是预后不佳的重要生物标志物.
- TIMP1表达与瘤免疫微环境和CRC中的免疫细胞透密切相关.
- TIMP1可能通过各种分子途径影响CRC进展,呈现潜在的治疗点.
更多相关视频
08:42Establishment of a Co-culture System of Patient-Derived Colorectal Tumor Organoids and Tumor-Infiltrating Lymphocytes (TILs)
Published on: June 27, 2025
1.9K
10:33Molecular Profiling of the Invasive Tumor Microenvironment in a 3-Dimensional Model of Colorectal Cancer Cells and Ex vivo Fibroblasts
Published on: April 29, 2014
11.4K
相关概念视频
Tumor Progression
7.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.2K
mTOR Signaling and Cancer Progression
4.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.6K
The Tumor Microenvironment
7.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.6K
Cancer-Critical Genes II: Tumor Suppressor Genes
9.3K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.3K
lncRNA - Long Non-coding RNAs
9.7K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.7K
